▶ 調査レポート

心嚢穿刺処置の世界市場2019-2027:疾患別(感染症、悪性腫瘍、炎症性/リウマチ、心臓、その他)、エンドユーザー別

• 英文タイトル:Pericardiocentesis Procedures Market (Indication: Infections, Malignancies, Inflammatory/Rheumatology, Cardiac, and Others; and End User: Hospitals, Cardiac Centers, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

Transparency Market Researchが調査・発行した産業分析レポートです。心嚢穿刺処置の世界市場2019-2027:疾患別(感染症、悪性腫瘍、炎症性/リウマチ、心臓、その他)、エンドユーザー別 / Pericardiocentesis Procedures Market (Indication: Infections, Malignancies, Inflammatory/Rheumatology, Cardiac, and Others; and End User: Hospitals, Cardiac Centers, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027 / TMR2006033資料のイメージです。• レポートコード:TMR2006033
• 出版社/出版日:Transparency Market Research / 2020年3月
• レポート形態:英文、PDF、180ページ
• 納品方法:Eメール
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥857,660 (USD5,795)▷ お問い合わせ
  Multi User¥1,301,660 (USD8,795)▷ お問い合わせ
  Corporate License¥1,745,660 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、心嚢穿刺処置の世界市場について、序論、仮定・調査手法、エグゼクティブサマリー、市場動向、キーインサイト、疾患別(感染症、悪性腫瘍、炎症性/リウマチ、心臓、その他)分析、エンドユーザー別分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東アフリカ)分析、競争状況などを総合的に調査・分析して掲載しております。
・序論
・仮定・調査手法
・エグゼクティブサマリー
・市場動向
・キーインサイト
・心嚢穿刺処置の世界市場規模:疾患別(感染症、悪性腫瘍、炎症性/リウマチ、心臓、その他)
・心嚢穿刺処置の世界市場規模:エンドユーザー別
・心嚢穿刺処置の世界市場規模:地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東アフリカ)
・競争状況

Pericardiocentesis Procedures Market – Scope of the Report

TMR’s report on the global pericardiocentesis procedures market studies the past as well as current growth trends and opportunities to gain valuable insights of these indicators for the market during the forecast period from 2019 to 2027. The report provides the revenue and volume (number of procedures) of the global pericardiocentesis procedures market for the period 2017–2027, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) of the global pericardiocentesis procedures market for the forecast period.

The report has been prepared after primary and secondary researches. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global pericardiocentesis procedures market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts have also employed a combination of top-down and bottom-up approaches to study various phenomena in the global pericardiocentesis procedures market.

The report includes an elaborate executive summary along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Additionally, the report sheds light on the changing competitive dynamics in the global pericardiocentesis procedures market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the global pericardiocentesis procedures market. The next section of the global pericardiocentesis procedures market report highlights the USPs, which include regulatory scenario, overview of large pericardial effusions, reimbursement scenario, and booming investments in private hospitals in India.

The report also delves into the competitive landscape of the global pericardiocentesis procedures market. Key players operating in the global pericardiocentesis procedures treatment market have been identified, and each one of these has been profiled for their distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players profiled in the global pericardiocentesis procedures treatment market report.

Key Questions Answered in Global Pericardiocentesis Procedures Market Report

What is the sales/revenue generated by different pericardiocentesis procedures across all the regions during the forecast period?
How many pericardiocentesis procedures were performed in 2018, by region/sub-region?
What are the major drivers, restraints, and opportunities in the global market?
Which region is set to expand at the fastest CAGR during the forecast period?
Which segment will have the highest revenue globally in 2027 and which segment will expand at the fastest CAGR during the forecast period?
Pericardiocentesis Procedures Market – Research Objectives and Approach

The comprehensive report on the global pericardiocentesis procedures market begins with an overview of the market, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of the objectives of the study and healthcare compliances laid down by accredited agencies in the purview of research in the global pericardiocentesis procedures market. It is followed by market introduction, market dynamics, and an overview of the global pericardiocentesis procedures market, which includes TMR analysis of market drivers, restraints, and trends affecting the growth of the market. Furthermore, Y-o-Y analysis with elaborate insights has been provided to understand the Y-o-Y trends of the pericardiocentesis procedures market. The next section of the global pericardiocentesis procedures market report highlights the USPs, including regulatory scenario, overview of large pericardial effusions, reimbursement scenario, and booming investments in private hospitals in India.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

Revenue generated and number of pericardiocentesis surgeries performed by key pericardiocentesis service providers has been mapped to ascertain the size of the global pericardiocentesis procedures market in terms of value and volume. The forecast presented here assesses the total revenue generated and number of pericardiocentesis procedures. In order to provide an accurate forecast, we took into consideration the parent cardiac tamponade market.

The report analyzes the global pericardiocentesis procedures market in terms of indication, end user, and region. Key segments under each criteria have been studied at length, and the market share for each of these at the end of 2027 has been provided. These valuable insights would help market stakeholders in making informed business decisions for investments in the pericardiocentesis procedures market.

レポート目次

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Pericardiocentesis Procedures Market

4. Market Overview

4.1. Introduction

4.1.1. Pericardiocentesis Procedures Introduction

4.2. Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global Pericardiocentesis Procedures Market Analysis and Forecast, 2017–2027

4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

5.1. Regulatory Scenario

5.2. Overview of Large Pericardial Effusions

5.3. Reimbursement Scenario

5.4. Booming investments in private hospitals in India

6. Global Pericardiocentesis Procedures Market Analysis and Forecast, by Indication

6.1. Introduction & Definition

6.2. Key Findings / Developments

6.3. Market Value Forecast, by Indication, 2017–2027

6.3.1. Infections

6.3.1.1. Tuberculosis Infection

6.3.1.2. Bacterial Infection

6.3.1.3. Others

6.3.2. Malignancies

6.3.2.1. Lung Cancer

6.3.2.2. Breast Cancer

6.3.2.3. Lymphoma

6.3.2.4. Others

6.3.3. Inflammatory/Rheumatology

6.3.3.1. Rheumatoid Arthritis

6.3.3.2. Systemic Lupus Erythromatosus

6.3.3.3. Others

6.3.4. Cardiac

6.3.5. Others

6.4. Market Attractiveness Analysis, by Indication

7. Global Pericardiocentesis Procedures Market Analysis and Forecast, by End-user

7.1. Introduction & Definition

7.2. Key Findings / Developments

7.3. Market Value Forecast, by End-user, 2017–2027

7.3.1. Hospitals

7.3.2. Cardiac Centers

7.3.3. Others

7.4. Market Attractiveness Analysis, by End-user

8. Global Pericardiocentesis Procedures Market Analysis and Forecast, by Region

8.1. Key Findings

8.2. Market Value Forecast, by Region

8.2.1. North America

8.2.2. Europe

8.2.3. Asia Pacific

8.2.4. Latin America

8.2.5. Middle East & Africa

8.3. Market Attractiveness Analysis, by Country/Region

9. North America Global Pericardiocentesis Procedures Market Analysis and Forecast

9.1. Introduction

9.2. Key Findings

9.3. Market Value Forecast, by Indication, 2017–2027

9.3.1. Infections

9.3.1.1. Tuberculosis Infection

9.3.1.2. Bacterial Infection

9.3.1.3. Others

9.3.2. Malignancies

9.3.2.1. Lung Cancer

9.3.2.2. Breast Cancer

9.3.2.3. Lymphoma

9.3.2.4. Others

9.3.3. Inflammatory/Rheumatology

9.3.3.1. Rheumatoid Arthritis

9.3.3.2. Systemic Lupus Erythromatosus

9.3.3.3. Others

9.3.4. Cardiac

9.3.5. Others

9.4. Market Value Forecast, by End-user, 2017–2027

9.4.1. Hospitals

9.4.2. Cardiac Centers

9.4.3. Others

9.5. Market Value Forecast, by Country, 2017–2027

9.5.1. U.S.

9.5.2. Canada

9.6. Market Attractiveness Analysis

9.6.1. By Indication

9.6.2. By End-user

9.6.3. By Country

10. Europe Global Pericardiocentesis Procedures Market Analysis and Forecast

10.1. Introduction

10.2. Key Findings

10.3. Market Value Forecast, by Indication, 2017–2027

10.3.1. Infections

10.3.1.1. Tuberculosis Infection

10.3.1.2. Bacterial Infection

10.3.1.3. Others

10.3.2. Malignancies

10.3.2.1. Lung Cancer

10.3.2.2. Breast Cancer

10.3.2.3. Lymphoma

10.3.2.4. Others

10.3.3. Inflammatory/Rheumatology

10.3.3.1. Rheumatoid Arthritis

10.3.3.2. Systemic Lupus Erythromatosus

10.3.3.3. Others

10.3.4. Cardiac

10.3.5. Others

10.4. Market Value Forecast, by End-user, 2017–2027

10.4.1. Hospitals

10.4.2. Cardiac Centers

10.4.3. Others

10.5. Market Value Forecast, by Country/Sub-region, 2017–2027

10.5.1. Germany

10.5.2. U.K.

10.5.3. France

10.5.4. Italy

10.5.5. Spain

10.5.6. Rest of Europe

10.6. Market Attractiveness Analysis

10.6.1. By Indication

10.6.2. By End-user

10.6.3. By Country/Sub-region

11. Asia Pacific Global Pericardiocentesis Procedures Market Analysis and Forecast

11.1. Introduction

11.2. Key Findings

11.3. Market Value Forecast, by Indication, 2017–2027

11.3.1. Infections

11.3.1.1. Tuberculosis Infection

11.3.1.2. Bacterial Infection

11.3.1.3. Others

11.3.2. Malignancies

11.3.2.1. Lung Cancer

11.3.2.2. Breast Cancer

11.3.2.3. Lymphoma

11.3.2.4. Others

11.3.3. Inflammatory/Rheumatology

11.3.3.1. Rheumatoid Arthritis

11.3.3.2. Systemic Lupus Erythromatosus

11.3.3.3. Others

11.3.4. Cardiac

11.3.5. Others

11.4. Market Value Forecast, by End-user, 2017–2027

11.4.1. Hospitals

11.4.2. Cardiac Centers

11.4.3. Others

11.5. Market Value Forecast, by Country/Sub-region, 2017–2027

11.5.1. China

11.5.2. India

11.5.3. Japan

11.5.4. Australia & New Zealand

11.5.5. Rest of Asia Pacific

11.6. Market Attractiveness Analysis

11.6.1. By Technique

11.6.2. By End-user

11.6.3. By Country/Sub-region

12. Latin America Global Pericardiocentesis Procedures Market Analysis and Forecast

12.1. Introduction

12.2. Key Findings

12.3. Market Value Forecast, by Indication, 2017–2027

12.3.1. Infections

12.3.1.1. Tuberculosis Infection

12.3.1.2. Bacterial Infection

12.3.1.3. Others

12.3.2. Malignancies

12.3.2.1. Lung Cancer

12.3.2.2. Breast Cancer

12.3.2.3. Lymphoma

12.3.2.4. Others

12.3.3. Inflammatory/Rheumatology

12.3.3.1. Rheumatoid Arthritis

12.3.3.2. Systemic Lupus Erythromatosus

12.3.3.3. Others

12.3.4. Cardiac

12.3.5. Others

12.4. Market Value Forecast, by End-user, 2017–2027

12.4.1. Hospitals

12.4.2. Cardiac Centers

12.4.3. Others

12.5. Market Value Forecast, by Country/Sub-region, 2017–2027

12.5.1. Brazil

12.5.2. Mexico

12.5.3. Rest of Latin America

12.6. Market Attractiveness Analysis

12.6.1. By Technique

12.6.2. By End-user

12.6.3. By Country/Sub-region

13. Middle East and Africa Global Pericardiocentesis Procedures Market Analysis and Forecast

13.1. Introduction

13.2. Key Findings

13.3. Market Value Forecast, by Indication, 2017–2027

13.3.1. Infections

13.3.1.1. Tuberculosis Infection

13.3.1.2. Bacterial Infection

13.3.1.3. Others

13.3.2. Malignancies

13.3.2.1. Lung Cancer

13.3.2.2. Breast Cancer

13.3.2.3. Lymphoma

13.3.2.4. Others

13.3.3. Inflammatory/Rheumatology

13.3.3.1. Rheumatoid Arthritis

13.3.3.2. Systemic Lupus Erythromatosus

13.3.3.3. Others

13.3.4. Cardiac

13.3.5. Others

13.4. Market Value Forecast, by End-user, 2017–2027

13.4.1. Hospitals

13.4.2. Cardiac Centers

13.4.3. Others

13.5. Market Value Forecast, by Country/Sub-region, 2017–2027

13.5.1. GCC Countries

13.5.2. South Africa

13.5.3. Rest of Middle East & Africa

13.6. Market Attractiveness Analysis

13.6.1. By Technique

13.6.2. By End-user

13.6.3. By Country/Sub-region

14. Competition Landscape

14.1. Market Player – Competition Matrix (By Tier and Size of companies)

14.2. Market Share Analysis, by Company, 2018

14.3. Company Profiles

14.3.1. New York-Presbyterian Hospital/Weill Cornell Medical Center

14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

14.3.1.2. Product Portfolio

14.3.1.3. SWOT Analysis

14.3.1.4. Strategic Overview

14.3.2. Florida Hospital Orlando

14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

14.3.2.2. Product Portfolio

14.3.2.3. SWOT Analysis

14.3.2.4. Strategic Overview

14.3.3. Cleveland Clinic

14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

14.3.3.2. Product Portfolio

14.3.3.3. SWOT Analysis

14.3.3.4. Strategic Overview

14.3.4. John Hopkins Hospital

14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

14.3.4.2. Product Portfolio

14.3.4.3. SWOT Analysis

14.3.4.4. Strategic Overview

14.3.5. Saint George Hospital

14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

14.3.5.2. Product Portfolio

14.3.5.3. SWOT Analysis

14.3.5.4. Strategic Overview

14.3.6. Buddhist Tzu Chi General Hospital

14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

14.3.6.2. Product Portfolio

14.3.6.3. SWOT Analysis

14.3.6.4. Strategic Overview

14.3.7. J. W. Goethe University Hospital

14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

14.3.7.2. Product Portfolio

14.3.7.3. SWOT Analysis

14.3.7.4. Strategic Overview

14.3.8. The University of Tokyo Hospital

14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

14.3.8.2. Product Portfolio

14.3.8.3. SWOT Analysis

14.3.8.4. Strategic Overview

14.3.9. Heart Institute, University of Sao Paulo

14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

14.3.9.2. Product Portfolio

14.3.9.3. SWOT Analysis

14.3.9.4. Strategic Overview

14.3.10. Mediclinic International

14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

14.3.10.2. Product Portfolio

14.3.10.3. SWOT Analysis

14.3.10.4. Strategic Overview

14.3.11. Apollo Hospitals Enterprise Ltd

14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)

14.3.11.2. Product Portfolio

14.3.11.3. SWOT Analysis

14.3.11.4. Strategic Overview

List of Tables

Table 01: Global Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Indication, 2017–2027

Table 02: Global Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Infections, 2017–2027

Table 03: Global Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Malignancies, 2017–2027

Table 04: Global Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Inflammatory/Rheumatologic, 2017–2027

Table 05: Global Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 06: Global Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Region, 2017–2027

Table 07: Global Pericardiocentesis Procedures Market Volume (Number of Procedures) Forecast, by Region, 2017–2027

Table 08: North America Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Country, 2017–2027

Table 09: North America Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Indication, 2017–2027

Table 10: North America Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Infections, 2017–2027

Table 11: North America Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Malignancies, 2017–2027

Table 12: North America Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Inflammatory/Rheumatologic, 2017–2027

Table 13: North America Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 14: Europe Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 15: Europe Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Indication, 2017–2027

Table 16: Europe Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Infections, 2017–2027

Table 17: Europe Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Malignancies, 2017–2027

Table 18: Europe Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Inflammatory/Rheumatologic, 2017–2027

Table 19: Europe Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 20: Asia Pacific Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 21: Asia Pacific Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Indication, 2017–2027

Table 22: Asia Pacific Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Infections, 2017–2027

Table 23: Asia Pacific Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Malignancies, 2017–2027

Table 24: Asia Pacific Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Inflammatory/Rheumatologic, 2017–2027

Table 25: Asia Pacific Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 26: Latin America Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 27: Latin America Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Indication, 2017–2027

Table 28: Latin America Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Infections, 2017–2027

Table 29: Latin America Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Malignancies, 2017–2027

Table 30: Latin America Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Inflammatory/Rheumatologic, 2017–2027

Table 31: Latin America Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 32: Middle East & Africa Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 33: Middle East & Africa Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Indication, 2017–2027

Table 34: Middle East & Africa Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Infections, 2017–2027

Table 35: Middle East & Africa Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Malignancies, 2017–2027

Table 36: Middle East & Africa Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Inflammatory/Rheumatologic, 2017–2027

Table 37: Middle East & Africa Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by End-user, 2017–2027